Re-expression of estrogen receptor α in estrogen receptor α-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling anal growth

Cancer Research

Volumn 61, Issue 15, 2001, Pages 5771-5777

  Oesterreich, Steffi ^a   Zhang, Ping ^a   Guler, Rebecca L ^a   Sun, Xiuhua ^a   Osborne, C Kent ^a   Lee, Adrian V ^a   Curran, Edward M ^b   Welshons, Wade V ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CYCLIN D1; ESTROGEN; ESTROGEN RECEPTOR ALPHA; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; PROGESTERONE RECEPTOR; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR;

ARTICLE; BREAST CANCER; CELL CLONE; CELL COUNT; CELL CYCLE S PHASE; CELL GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; GENE INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL DIVISION; CYCLIN D1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HEMAGGLUTININS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; PHOSPHOPROTEINS; PHOSPHORYLATION; RECEPTOR, IGF TYPE 1; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035423119     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Mammary gland development and tumorigenesis in estrogen receptor knockout mice
2. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development
3. Estradiol enhances the stimulatory effect of insulin-like growth factor- I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid
4. Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-I receptor and insulin receptor substrate-1 in the uterus
5. Modulation of insulin-like growth factor I (IGF-I) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol
6. Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo
7. Crosstalk between the insulin-like growth factors and estrogens in breast cancer
8. Insulin-like growth factor receptors and binding proteins
9. Differentiation and malignant transformation: Two roads diverged in a wood
10. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-I enhancer
11. Insulin-like growth factor-II (IGF-II): A potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor
12. Role of insulin-like growth factors and the type 1 insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells
13. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: A receptor saturation mechanism to increase the secretion of lysosomal proenzymes
14. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: Use of IGFBP-1 as an inhibitor of insulin-like growth factor action
15. Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182, 780 in breast cancer cells
16. Estrogen receptor α rapidly activates the IGF-I receptor pathway
17. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells
18. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
19. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I
20. Potentiation of estrogen receptor activation function I (AF-1) by Src/JNK through a serine 118-independent pathway
21. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167
22. Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780
23. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells
24. Extinction of insulin-like growth factor-I mitogenic signaling by antiestrogen-stimulated fas-associated protein tyrosine phosphatase-1 in human breast cancer cells
25. Insulin-like growth factor binding protein I expression inhibits insulin-like growth factor I action in MCF-7 cells
26. Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells
27. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice
28. Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells
29. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO
30. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation
31. Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line
32. The IRS-signaling system during insulin and cytokine action
33. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor
34. Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells
35. Characterization of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA
36. Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens
37. Stable transfection of the oestrogen receptor gene into a human osteosarcoma cell line
38. SK-ER3 neuroblastoma cells as a model for the study of estrogen influence on neural cells
39. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells
40. Stable over-expression of estrogen receptor-α in ECV304 cells inhibits proliferation and levels of secreted endothelin-1 and vascular endothelial growth factor
41. Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene
42. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor
43. Functional activity of ectopically expressed estrogen receptor is not sufficient for estrogen-mediated cyclin D1 expression
44. Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo
45. An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol
46. Proliferation, hormone responsiveness and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens
47. Adaption of oestrogen-dependent MCF-7 cells to low oestrogen (phenol red-free) culture
48. Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7
49. Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice
50. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells
51. Status of the insulin-like growth factor network in an estrogen receptor negative T47D breast cancer cell clone
52. IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells
53. Function of the insulin-like growth factor receptor I in metastatic breast cancer cells
54. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer
55. Type 1 IGF receptor in human breast diseases
56. Insulin-like growth factors in human breast cancer
57. The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients
58. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts
59. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation